Icad Inc (NASDAQ: ICAD)’s stock price has gone rise by 9.49 in comparison to its previous close of 1.58, however, the company has experienced a 10.90% increase in its stock price over the last five trading days. globenewswire.com reported 2024-11-26 that ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025 ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025
Is It Worth Investing in Icad Inc (NASDAQ: ICAD) Right Now?
The 36-month beta value for ICAD is also noteworthy at 1.42. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ICAD is 25.05M, and at present, short sellers hold a 0.99% of that float. The average trading volume of ICAD on November 27, 2024 was 178.35K shares.
ICAD’s Market Performance
ICAD’s stock has seen a 10.90% increase for the week, with a -10.36% drop in the past month and a 11.61% gain in the past quarter. The volatility ratio for the week is 10.23%, and the volatility levels for the past 30 days are at 9.09% for Icad Inc. The simple moving average for the past 20 days is -4.50% for ICAD’s stock, with a 10.58% simple moving average for the past 200 days.
Analysts’ Opinion of ICAD
Guggenheim, on the other hand, stated in their research note that they expect to see ICAD reach a price target of $24. The rating they have provided for ICAD stocks is “Buy” according to the report published on April 22nd, 2021.
BTIG Research gave a rating of “Buy” to ICAD, setting the target price at $25 in the report published on March 23rd of the previous year.
ICAD Trading at 0.55% from the 50-Day Moving Average
After a stumble in the market that brought ICAD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.71% of loss for the given period.
Volatility was left at 9.09%, however, over the last 30 days, the volatility rate increased by 10.23%, as shares sank -8.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +4.85% upper at present.
During the last 5 trading sessions, ICAD rose by +10.90%, which changed the moving average for the period of 200-days by +18.90% in comparison to the 20-day moving average, which settled at $1.8115. In addition, Icad Inc saw -2.26% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ICAD
Current profitability levels for the company are sitting at:
- -0.32 for the present operating margin
- 0.85 for the gross margin
The net margin for Icad Inc stands at -0.18. The total capital return value is set at -0.2. Equity return is now at value -17.56, with -12.79 for asset returns.
Currently, EBITDA for the company is -6.57 million with net debt to EBITDA at 3.69. When we switch over and look at the enterprise to sales, we see a ratio of 1.45. The receivables turnover for the company is 3.5for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.02.
Conclusion
In summary, Icad Inc (ICAD) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
